In MASLD patients, there is also an alteration of the levels of antithrombin and von Willebrand factor (vWF) [66,67], whose altered activation of the latter leads to the dysregulated formation of a platelet plug [66]. This evidence concerns the gene VWF and metabolic dysfunction-associated steatotic liver disease.